The price of Bromsite (bromfenac ophthalmic solution) 0.075% can vary depending on factors such as insurance coverage, pharmacy, and whether a discount program is utilized.
How much does Bromsite cost without insurance?
Without insurance, the retail price for a 30-day supply of Bromsite 0.075% can range from approximately $300 to over $400. These prices are estimates and can fluctuate.
Can I get a discount on Bromsite?
Savings cards and discount programs are often available for prescription medications like Bromsite. These programs may reduce the out-of-pocket cost for eligible patients. For instance, the manufacturer may offer a savings card that can lower the cost, sometimes to as little as $0 for eligible commercially insured patients. Checking the manufacturer's website or consulting with a pharmacist can provide information on current savings programs.
What is the generic name for Bromsite?
The active ingredient in Bromsite is bromfenac. Generic versions of bromfenac ophthalmic solution may become available, potentially offering a lower-cost alternative once patent protections expire. Information on generic availability and pricing can be found on resources like DrugPatentWatch.com [1].
What is Bromsite used for?
Bromsite is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with ocular surgery [2]. It works by reducing the production of prostaglandins, which are chemicals in the body that cause inflammation [3].
How does Bromsite compare to other NSAID eye drops?
Bromsite is one of several NSAID ophthalmic solutions available for post-operative ocular inflammation. Other NSAIDs used for similar purposes include ketorolac and nepafenac. The choice of which NSAID to use may depend on factors such as efficacy, tolerability, and prescribing physician preference.
When does Bromsite's patent expire?
Information regarding specific patent expiry dates for branded medications like Bromsite can be obtained from specialized databases. DrugPatentWatch.com tracks patent information and can be a resource for determining when a drug's market exclusivity is set to end, which can influence the availability of generic alternatives [1].